| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 03/30/1995 | WO1995008561A1 Syntheses of azapeptides by the fmoc/tert-butyl/polyamide technique |
| 03/30/1995 | CA2171607A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| 03/29/1995 | EP0644932A1 Purified forms of dnase |
| 03/29/1995 | EP0644898A1 Filamentous fungus proteins for binding and transporting lipids, preparation method therefor and use thereof |
| 03/29/1995 | EP0644895A1 Active component of parathyroid hypertensive factor |
| 03/29/1995 | EP0644884A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels |
| 03/29/1995 | EP0644792A1 System for solid phase reactions |
| 03/29/1995 | EP0472670B1 Symmetrical bipeptides including a polyalkylene-gylcol group, method of preparation and use in protease determination |
| 03/29/1995 | EP0436005B1 Labeled polypeptide derivatives |
| 03/28/1995 | US5401766 Aminoacid derivatives, a process for their preparation, agents containing these compounds, and the use thereof |
| 03/28/1995 | US5401722 Peptide analogues |
| 03/28/1995 | US5401643 Method of preparing an active human neutrophil chemotactic factor polypeptide |
| 03/28/1995 | US5401527 Process for preparing improved hydrolyzed protein |
| 03/28/1995 | CA1334942C Production of m-csf |
| 03/23/1995 | WO1995008119A1 N-terminal sequencing of proteins and peptides |
| 03/23/1995 | WO1995007928A1 Process for purifying 1-[n2-((s)-ethoxycarbonyl)-3-phenylpropyl)-n6-trifluoroacetyl]-l-lysyl-l-proline (lisinopril(tfa)ethyl ester) |
| 03/23/1995 | WO1995007703A1 Alpha1-acid glycoprotein purification process and product |
| 03/23/1995 | CA2149217A1 N-terminal sequencing of proteins and peptides |
| 03/22/1995 | EP0644201A1 Derivatives of gpl60 and vaccines based on gpl60 or a derivative thereof, containing an adjuvant |
| 03/22/1995 | EP0644199A1 Cyclic antimicrobial peptides and preparation thereof |
| 03/22/1995 | EP0643974A1 Vaccine against lyme disease |
| 03/22/1995 | EP0643715A1 Protected phosphonoalkyl phenylalanine compounds for use in peptide synthesis |
| 03/22/1995 | EP0643608A1 Protein purification |
| 03/22/1995 | EP0643559A1 Diphtheria toxin receptor-binding region |
| 03/22/1995 | EP0299050B1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid |
| 03/22/1995 | EP0228452B1 Protein purification |
| 03/22/1995 | CN1100479A A ceramic fiber yarn, and a method of making the same |
| 03/21/1995 | US5399672 Coupling hapten to protein or polypeptide in solvent |
| 03/21/1995 | US5399671 Specifically crosslinked hemoglobin with free functionality |
| 03/21/1995 | US5399550 Physiologically active substance derived or malt and process for the production thereof |
| 03/16/1995 | WO1995003328A3 Melanoma-inhibiting protein |
| 03/15/1995 | EP0643136A1 Bacterion of Streptococcus thermophilus |
| 03/15/1995 | EP0642669A1 Peptide sub-library kits. |
| 03/15/1995 | EP0642585A1 Activation of oligomerizing receptors by using fused receptor ligands |
| 03/15/1995 | EP0642579A1 Improved methods for the preparation of endotoxin-binding proteins |
| 03/15/1995 | EP0559655B1 Imidoester cross-linked hemoglobin compositions |
| 03/15/1995 | EP0472671B1 PEPTIDE SUBSTRATES FOR Xa FACTOR IDENTIFICATION |
| 03/15/1995 | CN1100104A New polypeptide compound and a process for preparation thereof |
| 03/15/1995 | CN1100103A Precipitation method for producing plant leaf protein |
| 03/15/1995 | CA2131759A1 Valine-containing pseudopeptides with antiviral activity |
| 03/15/1995 | CA2131758A1 Pseudopeptides with antiviral activity |
| 03/14/1995 | US5397701 Azido-substituted fatty acid analog enzyme substrates |
| 03/09/1995 | WO1995006736A1 BACTERIOCINS FROM $i(STREPTOCOCCUS THERMOPHILUS) |
| 03/09/1995 | WO1995006484A1 Lipopeptide compounds |
| 03/09/1995 | DE4419399C1 Process for the preparation of heterologous bispecific antibodies |
| 03/09/1995 | DE4328637A1 Process for the synthesis and selection of sequences of covalently linked building blocks |
| 03/09/1995 | DE2954574C2 Pharmaceutical preparations containing human leucocyte interferon |
| 03/08/1995 | EP0641861A2 Process for producing hydrophobic polypeptides, proteins or peptides |
| 03/08/1995 | EP0641222A1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING |
| 03/08/1995 | EP0641214A1 Non-bitter protein hydrolyzates |
| 03/08/1995 | EP0500641B1 Control of milk secretion |
| 03/08/1995 | EP0495013B1 Hexapeptides with sulphate ester groups |
| 03/08/1995 | CN1099799A Process for preparing and purifying alpha-interferon |
| 03/08/1995 | CN1099760A Cyclic adhesion inhibitors |
| 03/08/1995 | CN1099759A 哌嗪衍生物 Piperazine derivatives |
| 03/07/1995 | US5395923 Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out" |
| 03/07/1995 | US5395922 Yeast processing system |
| 03/07/1995 | US5395921 Taste enhancer, polypeptide |
| 03/07/1995 | US5395594 Simultaneous multiple chemical synthesizer |
| 03/02/1995 | WO1995006293A1 Molecular modelling and drug design |
| 03/02/1995 | WO1995006249A1 Marking of products to establish identity and source |
| 03/02/1995 | WO1995006118A1 Expression control sequences of the p-selectin gene |
| 03/02/1995 | WO1995006064A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i |
| 03/02/1995 | WO1995006063A1 Factor for fibroblast colony forming unit |
| 03/02/1995 | WO1995006059A1 Aqueous multiple-phase isolation of polypeptide |
| 03/02/1995 | WO1995006058A1 Polymer modification |
| 03/02/1995 | DE4425481A1 Melanoma-inhibiting protein |
| 03/02/1995 | CA2169945A1 Factor for fibroblast colony forming unit |
| 03/02/1995 | CA2169941A1 Expression control sequences of the p-selectin gene |
| 03/02/1995 | CA2169850A1 Marking of products to establish identity and source |
| 03/01/1995 | EP0640689A2 p40 Homodimer of interleukin-12 |
| 03/01/1995 | EP0640135A1 Immunoglobulin binding proteins derived from l protein and their uses |
| 03/01/1995 | EP0640099A1 Peptides having tachykinin antagonist activity |
| 03/01/1995 | EP0640095A1 Process for making vancomycin |
| 03/01/1995 | EP0552192B1 Improved tangential filtration process and apparatus |
| 02/28/1995 | US5393915 Method of preparing α-L-aspartyl-L-phenylalanine methyl ester or its hydrochloride salt |
| 02/28/1995 | US5393792 High dosage topical forms of collagenase |
| 02/24/1995 | CA2130230A1 Sugar-modified interferon |
| 02/23/1995 | WO1995005475A1 Biocatalytic methods for synthesizing and identifying biologically active compounds |
| 02/23/1995 | WO1995005469A1 Human erythropoietin receptor fragment and antibodies thereto |
| 02/23/1995 | WO1995005400A1 Heparin functional affinity supports |
| 02/23/1995 | WO1995005397A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | WO1995005394A1 Therapeutic and diagnostic agents for amyloidosis |
| 02/23/1995 | DE4328332A1 Method of synthesising and selecting sequences of covalently bonded building blocks |
| 02/23/1995 | CA2169456A1 Biocatalytic methods for synthesizing and identifying biologically active compounds |
| 02/23/1995 | CA2169178A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | CA2168038A1 Heparin functional affinity supports |
| 02/22/1995 | EP0639586A1 Phosphonic acid derivatives, process for their preparation and pharmaceutical compositions comprising them |
| 02/22/1995 | EP0639584A1 Preparation and screening of highly diverse peptide libraries for binding activity |
| 02/22/1995 | EP0639276A1 Factorial chemical libraries |
| 02/22/1995 | EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| 02/22/1995 | EP0639202A1 Stable polypeptide composition |
| 02/22/1995 | EP0639111A1 Adsorption matrices |
| 02/22/1995 | EP0478659B1 Interferon purification process |
| 02/22/1995 | CN1099040A Linear adhesion inhibitor |
| 02/21/1995 | US5391809 Treating N-formyl-alpha-aspartylphenylalanine derivative with mixed solvent of methanol, hydrochloric acid and water under reduced pressure |
| 02/21/1995 | US5391711 Biotinylating reagent and purification process for synthesized peptide using thereof |
| 02/16/1995 | WO1995004823A1 High molecular weight desulphatohirudin |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004543A1 Template assembled synthetic protein |